Fresenius medical care spain

Every year, more than 22 million patients opt for medical treatment at a Fresenius Helios hospital.

Under this agreement, Fresenius Medical Care will provide dialysis therapy to approximately renal patients in the region. The contract will be effective from mid Currently, the Company provides dialysis treatment to more than 5, patients in 64 dialysis clinics. According to the Spanish Society of Nephrology, about 1, patients per 1 million individuals need renal replacement therapy in Spain in the form of dialysis or transplantation to survive. The region is one of the country's 17 autonomous communities. In Spain, regional governments are responsible for the administration of health, social and other services.

Fresenius medical care spain

Dialysis is a vital blood cleansing procedure that substitutes the function of the kidneys in case of kidney failure. Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. We care for more than , patients in our global network of roughly 4, dialysis clinics. At the same time, we operate around 40 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables. Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable profitable growth. Developing innovative products and continuously improving our renal therapies are intrinsic elements of our growth strategy. Our worldwide research and development activities, which are centrally managed by the Global Research and Development division GRD , enable us to develop products and renal therapies efficiently and to systematically promote the exchange of knowledge and technology between regions. Health care systems face major financial challenges. We aim to direct our research and development activities toward developing innovative products and renal therapies that not only meet high quality standards that improve clinical outcomes but are also affordable. As an operator of proprietary dialysis clinics and a provider of products for treating patients at home, we believe that these aims are entirely compatible. Our research and development strategy contributes to our corporate strategy which aims to provide health care for chronically and critically ill patients across the renal care continuum by developing adjacent products and therapies for Extracorporeal Membrane Oxygenation, as well as by acquiring and developing complementary assets.

Managing sustainability successfully means creating lasting value — economically, ecologically and socially. Carrying out research and development responsibly is an intrinsic element of our innovative culture.

.

Fresenius makes important contributions to high-quality and affordable medical care worldwide. In this way, we are living up to our social responsibility. We met our targets, which improved in the course of the year. KGaA a partnership limited by shares. In addition, Fresenius focuses on hospital operations. We also manage projects and provide services for hospitals and other health care facilities worldwide. Group structure. Fresenius has an international sales network and maintains more than 90 production sites.

Fresenius medical care spain

We made progress on every part of our FutureFresenius program, including simplification of our corporate structure, and achieved cost savings well ahead of our targets for the full year At the same time, we are moving ahead with the divestment of non-core businesses. The focus on our two Operating Companies, Kabi and Helios, is paying off, with strong revenue and earnings development. Both businesses again announced important innovations, new products and strong partnerships to improve patient outcomes. And this gets a lot of recognition even beyond the industry.

Letterboxd for books

Dialysis is a vital blood cleansing procedure that substitutes the function of the kidneys in case of kidney failure. Development activities in Shanghai and Changshu China are focused on the growing demand for cost-effective dialysis systems in Asia and emerging markets. Other development sites are in St. In total, Fresenius employs around 4, people in Brazil. The plant employs about 1, people. Around The region is one of the country's 17 autonomous communities. At the end of , our patent portfolio comprised some 9, property rights in approximately 1, patent families, i. In Friedberg, Germany, Fresenius Kabi operates a state of the art production facility for infusion solutions. The acquisition of Hiplex, a pharmaceutical company specializing in infusion solutions and based in Campinas, Sao Paulo state, followed in Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable profitable growth. In the U. Our worldwide research and development activities, which are centrally managed by the Global Research and Development division GRD , enable us to develop products and renal therapies efficiently and to systematically promote the exchange of knowledge and technology between regions. On December 31, , 1, employees total headcount worked for Fresenius Medical Care in research and development worldwide December 31, 1, Every year, more than 22 million patients opt for medical treatment at a Fresenius Helios hospital.

Under this agreement, Fresenius Medical Care will provide dialysis therapy to approximately renal patients in the region.

Other development sites are in St. China has played a major role in the development of Fresenius. Fresenius Kabi Brasil Ltda. Skip to content Home Media Newsroom Fresenius Medical Care awarded first contract for comprehensive dialysis care and performance-oriented reimbursement in Spain. Fresenius Kabi and Fresenius Medical Care both have their own plants in the country, and Fresenius Medical Care also operates dialysis clinics. More than employees — the majority of our research and development staff — are based in Europe. Health care systems face major financial challenges. Related content. The region is one of the country's 17 autonomous communities. It is the market leader in parenteral nutrition , a leading supplier of infusion therapies , and one of the largest foreign-based pharmaceutical companies in the country. We performed around 52 million dialysis treatments in The size of hospitals and their equipment can be individually adapted using various standard modules. Being acquired by Helios is bringing the Krefeld municipal hospital back on track. In Africa, VAMED has been working with several governments for many years to address the top priority of nationwide access to basic health care.